A carregar...

In vivo production of a novel glycoconjugate vaccine against Shigella flexneri 2a in recombinant Escherichia coli: identification of stimulating factors for in vivo glycosylation

BACKGROUND: Glycoconjugated vaccines composed of polysaccharide antigens covalently linked to immunogenic carrier proteins have proved to belong to the most effective and safest vaccines for combating bacterial pathogens. The functional transfer of the N-glycosylation machinery from Campylobacter je...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Microb Cell Fact
Main Authors: Kämpf, Michael M, Braun, Martin, Sirena, Dominique, Ihssen, Julian, Thöny-Meyer, Linda, Ren, Qun
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4308876/
https://ncbi.nlm.nih.gov/pubmed/25612741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12934-015-0195-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!